Latest findings, practices, and strategies to detect and control nosocomial infections
Nosocomial infections, also known as hospital acquired infections, represent a growing challenge to healthcare facilities around the world. Many nosocomial pathogens are becoming more and more resistant to treatment, resulting in higher morbidity, mortality, and cost. In fact, each year it is estimated that some two million patients develop a hospital-acquired infection in the United States, representing nearly 5% of all hospitalized patients.
Molecular Techniques for the Study of Hospital Acquired Infection reviews the latest findings, practices, and strategies to support the development and implementation of effective, comprehensive programs to study and control hospital acquired infections. It focuses on the application of molecular techniques, enabling hospitals to incorporate these state-of-the-technology techniques into their infection control programs.
Key topics include:
-
Characteristics of healthcare settings that allow for the development and spread of nosocomial pathogens
-
Implementation of effective infection control programs
-
Epidemiological methods to study nosocomial disease
-
Elimination of pathogens and the development of resistance to treatment
-
Molecular techniques to study hospital acquired infections and their application in characterizing important Gram-positive, Gram-negative, and fungal pathogens
Contributions come from leading international experts in nosocomial pathogen detection and control. These contributions are based on the authors’ own firsthand experience combined with a thorough review and analysis of the current literature. References at the end of each chapter enable readers to explore each individual topic in greater depth.
Molecular Techniques for the Study of Hospital Acquired Infection is highly recommended as a guide for hospital infection control programs. Moreover, it serves as a text for courses in infection control and the population biology of nosocomial infection. In particular, the book’s unique clinical perspective helps readers minimize nosocomial infections by developing a coordinated approach to infection control, laboratory methods, and clinical practices.
From the Back Cover
Latest findings, practices, and strategies to detect and control nosocomial infections
Nosocomial infections, also known as hospital acquired infections, represent a growing challenge to healthcare facilities around the world. Many nosocomial pathogens are becoming more and more resistant to treatment, resulting in higher morbidity, mortality, and cost. In fact, each year it is estimated that some two million patients develop a hospital-acquired infection in the United States, representing nearly 5% of all hospitalized patients.
Molecular Techniques for the Study of Hospital Acquired Infection reviews the latest findings, practices, and strategies to support the development and implementation of effective, comprehensive programs to study and control hospital acquired infections. It focuses on the application of molecular techniques, enabling hospitals to incorporate these state-of-the-technology techniques into their infection control programs.
Key topics include:
-
Characteristics of healthcare settings that allow for the development and spread of nosocomial pathogens
-
Implementation of effective infection control programs
-
Epidemiological methods to study nosocomial disease
-
Elimination of pathogens and the development of resistance to treatment
-
Molecular techniques to study hospital acquired infections and their application in characterizing important Gram-positive, Gram-negative, and fungal pathogens
Contributions come from leading international experts in nosocomial pathogen detection and control. These contributions are based on the authors’ own firsthand experience combined with a thorough review and analysis of the current literature. References at the end of each chapter enable readers to explore each individual topic in greater depth.
Molecular Techniques for the Study of Hospital Acquired Infection is highly recommended as a guide for hospital infection control programs. Moreover, it serves as a text for courses in infection control and the population biology of nosocomial infection. In particular, the book’s unique clinical perspective helps readers minimize nosocomial infections by developing a coordinated approach to infection control, laboratory methods, and clinical practices.
About the Author
Shabbir Simjee, Ph.D. is a Senior Microbiologist at Eli Lilly & Company, where he specializes in antimicrobial susceptibility testing and the interpretation of antimicrobial susceptibility data according to NCCLS and BSAC standards. He has served as Editor of The Journal of Antimicrobial Chemotherapy and currently serves as an Editorial Board Member for Antimicrobial Agents and Chemotherapy as well as Section Editor (Molecular Microbiology) for the International Journal of Antimicrobial Agents. Dr. Simjee has served on a number of FDA advisory committees.
Steven Foley, Ph.D. is an Associate Research Scientist for the National Farm Medicine Center, Marshfield Clinic Research Foundation, as well as Clinical Professor of Clinical Microbiology at the University of Wisconsin. His research interests include understanding the mechanisms that Escherichia coli employ to resist being killed by vertebrate immune system constituents and the development and utilization of genotypic and phenotypic methods to track enteric bacterial pathogens and their virulence and antimicrobial resistance factors through the food animal production environment.
Anne Chen, M.D. is a Senior Staff Physician, Division of Infectious Diseases at the Henry Ford Hospital, Detroit, Michigan as well as Assistant Professor of Medicine at Wayne State University School of Medicine. She is Board Certified in Internal Medicine and Infectious Disease and is currently researching Candida epidemiology in the burn unit.
Marcus J. Zervos, M.D. is the Medical Director of Infection Control and Division Head of Infectious Disease, Department of Internal Medicine at Henry Ford Hospital as well as Clinical Professor of Medicine in the Department of Internal Medicine, Infectious Diseases Section at Wayne State University School of Medicine. He chairs the Infection Control Committee at the Henry Ford Hospital and is certified by the American Board of Internal Medicine and Infectious Diseases. Dr. Zervos serves on the boards of several journals in infectious disease, microbiology and internal medicine, including Infectious Diseases in Clinical Practice and his role as Section Editor for the journal Infection Control and Hospital Epidemiology.
Wow! eBook
